论文部分内容阅读
我们自1996年8月～1998年8月采用干扰素联合乙肝散治疗慢性乙型肝炎患者45例,取得较好疗效,现报告如下。 1 一般资料 135例慢性乙型肝炎患者均为我院肝病科住院或门诊病人,诊断及分型均符合1995年北京第5次全国传染病寄生虫病学术会议修订的标准。其HBeAg、HBV DNA均为阳性。所有病例均符合干扰素应用指征。随机分为3组,治疗组45例,男30例,女15例,年龄20～50岁,对照Ⅰ组及对照Ⅱ组各45例,其病程、分型均有可比性(P>0.05),所有病例在治疗前均未使用抗病毒药物。
We from August 1996 to August 1998 with interferon combined with hepatitis B scattered treatment of chronic hepatitis B patients 45 cases, achieved good effect, are as follows. 1 General Information 135 cases of chronic hepatitis B patients are hospitalized or outpatient department of hepatology in our hospital, diagnosis and classification are in line with the 1995 Beijing Fifth National Conference on Infectious Diseases Parasitic Diseases revised standards. The HBeAg, HBV DNA are positive. All cases were in line with interferon application indications. The patients were randomly divided into 3 groups: 45 cases in the treatment group, 30 males and 15 females, aged from 20 to 50 years old. The control group Ⅰ and the control group Ⅱ 45 cases each had comparable disease duration and type (P> 0.05) All cases did not use antiviral drugs before treatment.